|
SEC24D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.006790E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.655000E-01 |
| Normal-vs-Stage2 |
2.718800E-01 |
| Normal-vs-Stage3 |
2.623800E-02 |
| Normal-vs-Stage4 |
3.557000E-01 |
| Stage1-vs-Stage2 |
2.917600E-01 |
| Stage1-vs-Stage3 |
2.294300E-02 |
| Stage1-vs-Stage4 |
3.505000E-01 |
| Stage2-vs-Stage3 |
2.088800E-01 |
| Stage2-vs-Stage4 |
5.573000E-01 |
| Stage3-vs-Stage4 |
9.827200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.478170E-01 |
| Normal-vs-AfricanAmerican |
5.249400E-01 |
| Normal-vs-Asian |
2.720600E-01 |
| Caucasian-vs-AfricanAmerican |
5.979400E-01 |
| Caucasian-vs-Asian |
8.204800E-01 |
| AfricanAmerican-vs-Asian |
6.308600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.115400E-01 |
| Normal-vs-Female |
1.919510E-03 |
| Male-vs-Female |
1.817810E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.104400E-01 |
| Normal-vs-Extreme_Weight |
9.941400E-01 |
| Normal-vs-Obese |
5.048000E-02 |
| Normal-vs-Extreme_Obese |
3.961900E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.111600E-01 |
| Normal_Weight-vs-Obese |
2.444000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.996200E-02 |
| Extreme_Weight-vs-Obese |
4.783700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.193560E-01 |
| Obese-vs-Extreme_Obese |
3.417300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.322400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.137900E-02 |
| Normal-vs-Age(61-80Yrs) |
8.403600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.286000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.435760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.906100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.963700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.308300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.644200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.938770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.134400E-01 |
| Normal-VS-Type2 PRCC |
2.876800E-01 |
| Normal-VS-KIRP CIMP |
1.594090E-02 |
| Normal-VS-Unclassified PRCC |
5.621500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.038760E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.354470E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.798970E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.414300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.274200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.856200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.438800E-01 |
| Normal-vs-N1 |
2.367600E-02 |
| Normal-vs-N2 |
2.653600E-01 |
| N0-vs-N1 |
1.039760E-01 |
| N0-vs-N2 |
3.048000E-01 |
| N1-vs-N2 |
4.507000E-01 |
|
|
